Einstein PETAL: Clinical Center for the PETAL Network

爱因斯坦 PETAL:PETAL 网络临床中心

基本信息

  • 批准号:
    8704533
  • 负责人:
  • 金额:
    $ 14.42万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-06-17 至 2021-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The overall aim of this proposal is to establish Einstein-PETAL under the Albert Einstein College of Medicine as a Clinical Center in the PETAL Network. The specific aims of Einstein-PETAL are: 1) To optimize the identification and recruitment of a diverse population of patients into PETAL trials by building upon the expertise and established collaboration between critical care and emergency medicine. 2) To facilitate the efficiency and operation of the PETAL Network by leveraging the local and national infrastructure, resources, and expertise of the sites and PIs, including the US Critical Illness an Injuries Trials Group, the CTSA supported Einstein- Montefiore Institute of Clinical and Translational Research (ICTR) with its multiple cores including the Einstein-Montefiore ICTR Clinical Research Informatics Core (RIC), and the electronic medical records at each site. 3) To propose for PETAL two significant clinical trials (Checklist for Lung Injury Prevention (CLIP) and Lung Injury Prevention Study Aspirin II (LIPS-A II)) aimed at the prevention of ARDS and mortality in patients at high risk for ARDS. To achieve these objectives, we have assembled institutions in New York City with outstanding clinical and academic critical care and emergency medicine delivery systems. These sites include the Montefiore Medical Center and its satellite site, the Mount Sinai Medical Center. Together these sites in Manhattan and the Bronx represent 126 adult medical and surgical intensive care unit beds that admitted 6,873 patients in 2012, a busy critical care consultative / rapid response team that sees over 6,619 patients a year, and one of the busiest EDs in the country with over 350,000 adult visits a year. The critical care and emergency medicine services are supplemented by strong institutional research infrastructure and support. The deliverables will include: participation of the PI and co-PI, with their expertise in ARDS prevention and emergency research, on the PETAL steering committees, a commitment to enroll 40 patients a year for the 5 1/2 years of enrollment into PETAL trials, and to implement high quality and timely study procedures and data and sample collection, as per our objectives above.
描述(由申请人提供):本提案的总体目标是将爱因斯坦医学院下属的Einstein-PETAL建立为PETAL网络中的临床中心。Einstein-PETAL的具体目标是:1)通过建立重症监护和急诊医学之间的专业知识和已建立的合作,优化PETAL试验中不同患者群体的识别和招募。2)为了促进PETAL网络的效率和运作,利用当地和国家的基础设施、资源和站点和pi的专业知识,包括美国重大疾病和伤害试验小组,CTSA支持爱因斯坦-蒙蒂菲奥里临床和转化研究所(ICTR)的多个核心,包括爱因斯坦-蒙蒂菲奥里ICTR临床研究信息学核心(RIC),以及每个站点的电子医疗记录。3)为PETAL提出两项具有重要意义的临床试验(肺损伤预防检查表(CLIP)和肺损伤预防研究阿司匹林II (LIPS-A II)),旨在预防ARDS高危患者的ARDS和死亡率。为了实现这些目标,我们在纽约市集合了拥有优秀临床和学术重症监护和急诊医学交付系统的机构。这些地点包括蒙特菲奥里医疗中心及其卫星站点西奈山医疗中心。这些位于曼哈顿和布朗克斯的医院共有126张成人医疗和外科重症监护病房床位,2012年收治了6873名患者,是一个繁忙的重症监护咨询/快速反应团队,每年接待超过6619名患者,是全国最繁忙的急诊室之一,每年接待超过35万名成人就诊。的关键

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHELLE Ng GONG其他文献

MICHELLE Ng GONG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHELLE Ng GONG', 18)}}的其他基金

TREAT ECARDS: Translating Evidence into Action: Electronic Clinical Decision Support in ARDS
TREAT ECARDS:将证据转化为行动:ARDS 中的电子临床决策支持
  • 批准号:
    9763432
  • 财政年份:
    2018
  • 资助金额:
    $ 14.42万
  • 项目类别:
Digital Implementation Intervention Trials in Acute Lung Care (DIGITAL-C) Network Planning
急性肺护理数字化实施干预试验 (DIGITAL-C) 网络规划
  • 批准号:
    9756472
  • 财政年份:
    2018
  • 资助金额:
    $ 14.42万
  • 项目类别:
Utilizing Innovative Technology To Improve Compliance With Patient Elevation Guidelines – The Impact Of Angulus On Adherence To The Evidence-Based VAP-Prevention Bundle
利用创新技术提高患者抬高指南的合规性 — Angulus 对遵守循证 VAP 预防捆绑包的影响
  • 批准号:
    9139729
  • 财政年份:
    2016
  • 资助金额:
    $ 14.42万
  • 项目类别:
Einstein PETAL: Clinical Center for the PETAL Network
爱因斯坦 PETAL:PETAL 网络临床中心
  • 批准号:
    9172481
  • 财政年份:
    2014
  • 资助金额:
    $ 14.42万
  • 项目类别:
Einstein PETAL: Clinical Center for the PETAL Network
爱因斯坦 PETAL:PETAL 网络临床中心
  • 批准号:
    9062498
  • 财政年份:
    2014
  • 资助金额:
    $ 14.42万
  • 项目类别:
Early Insulin Therapy and Development of ARDS
早期胰岛素治疗和 ARDS 的发展
  • 批准号:
    7491770
  • 财政年份:
    2007
  • 资助金额:
    $ 14.42万
  • 项目类别:
Early Insulin Therapy and Development of ARDS
早期胰岛素治疗和 ARDS 的发展
  • 批准号:
    7866687
  • 财政年份:
    2007
  • 资助金额:
    $ 14.42万
  • 项目类别:
Early Insulin Therapy and Development of ARDS
早期胰岛素治疗和 ARDS 的发展
  • 批准号:
    7313911
  • 财政年份:
    2007
  • 资助金额:
    $ 14.42万
  • 项目类别:
Early Insulin Therapy and Development of ARDS
早期胰岛素治疗和 ARDS 的发展
  • 批准号:
    8057652
  • 财政年份:
    2007
  • 资助金额:
    $ 14.42万
  • 项目类别:
Surrogate Consent in Research
研究中的替代同意书
  • 批准号:
    7868027
  • 财政年份:
    2006
  • 资助金额:
    $ 14.42万
  • 项目类别:

相似海外基金

Un/kindness, shame & resistance: the care of inpatients in NHS adult acute mental health units and how it might be improved
Un/善良,羞耻
  • 批准号:
    2885806
  • 财政年份:
    2023
  • 资助金额:
    $ 14.42万
  • 项目类别:
    Studentship
Post-Acute Care Transitions for Older Adult Medicare Beneficiaries with Serious Mental Illness
患有严重精神疾病的老年医疗保险受益人的急性后护理过渡
  • 批准号:
    10772386
  • 财政年份:
    2023
  • 资助金额:
    $ 14.42万
  • 项目类别:
Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
通过 CAR-T 细胞疗法为加拿大护理标准铺平道路:CD19 CAR-T 治疗复发/难治性成人急性淋巴细胞白血病的 II 期试验 (CLIC-01A)
  • 批准号:
    474619
  • 财政年份:
    2022
  • 资助金额:
    $ 14.42万
  • 项目类别:
    Operating Grants
Investigating the impact acute inhalation of cannabis with a high content of delta-9-tetrahydrocannabinol has on myelination and microglia in adult and aged mice
研究急性吸入高含量 delta-9-四氢大麻酚的大麻对成年和老年小鼠髓鞘形成和小胶质细胞的影响
  • 批准号:
    485965
  • 财政年份:
    2022
  • 资助金额:
    $ 14.42万
  • 项目类别:
    Studentship Programs
Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
通过 CAR-T 细胞疗法为加拿大护理标准铺平道路:CD19 CAR-T 治疗复发/难治性成人急性淋巴细胞白血病的 II 期试验 (CLIC-01A)
  • 批准号:
    466358
  • 财政年份:
    2022
  • 资助金额:
    $ 14.42万
  • 项目类别:
    Operating Grants
Metabolomics for prediction of cisplatin mediated acute kidney injury: a Canadian multi-centre adult and pediatric study
预测顺铂介导的急性肾损伤的代谢组学:加拿大多中心成人和儿童研究
  • 批准号:
    402040
  • 财政年份:
    2019
  • 资助金额:
    $ 14.42万
  • 项目类别:
    Operating Grants
Study of pathogenic mechanism of age-dependent chromosome translocation in adult acute lymphoblastic leukemia
成人急性淋巴细胞白血病年龄依赖性染色体易位发病机制研究
  • 批准号:
    18K16103
  • 财政年份:
    2018
  • 资助金额:
    $ 14.42万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Causal effect of time-varying driving pressures on mortality in mechanically ventilated, adult patients with acute respiratory distress syndrome
时变驱动压力对机械通气成年急性呼吸窘迫综合征患者死亡率的因果影响
  • 批准号:
    377313
  • 财政年份:
    2017
  • 资助金额:
    $ 14.42万
  • 项目类别:
    Studentship Programs
Role of SETBP1 in adult Ph+ acute lymphoblastic leukemia
SETBP1 在成人 Ph 急性淋巴细胞白血病中的作用
  • 批准号:
    9315111
  • 财政年份:
    2016
  • 资助金额:
    $ 14.42万
  • 项目类别:
Acute Inhibition of Adult-born Granule Cells and its Effect on Antidepressant Act
成体颗粒细胞的急性抑制及其抗抑郁作用
  • 批准号:
    8734273
  • 财政年份:
    2013
  • 资助金额:
    $ 14.42万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了